Globus Medical Inc. (GMED) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026
Summary
Globus Medical’s revenue went from $564M in fiscal 2016 to $2.9B in fiscal 2025, growth of about 20.1% a year.
Net income in fiscal 2025 was $538M, a net margin of 18.3%; the highest of the period.
Over the twelve months to September 30, 2026, revenue was $3.1B and net income $558M.
Free cash flow was $589M in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count rose 42% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.1B | $2.9B | $2.5B | $1.6B | $1.0B | $958M | $789M | $785M | $713M | $636M | $564M |
| Gross profit | $2.2B | $2.0B | $1.5B | $1.0B | $759M | $719M | $572M | $605M | $554M | $486M | $429M |
| Operating income | $680M | $480M | $166M | $133M | $228M | $172M | $111M | $172M | $169M | $162M | $154M |
| Net income | $558M | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M |
| EPS (diluted) | $4.06 | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 |
| R&D | $144M | $147M | $164M | $124M | $73M | $97M | $85M | $60M | $55M | $44M | $45M |
| Revenue growth | — | +16.7% | +60.6% | +53.3% | +6.8% | +21.4% | +0.5% | +10.2% | +12.1% | +12.8% | +3.5% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $926M | $753M | $521M | $243M | $178M | $276M | $199M | $172M | $182M | $159M | $148M |
| Capital spending | -$159M | -$165M | -$115M | -$78M | -$74M | -$57M | -$64M | -$71M | -$60M | -$51M | -$41M |
| Free cash flow | $767M | $589M | $405M | $165M | $104M | $219M | $135M | $101M | $122M | $108M | $107M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | $324M | $300M | $86M | $226M | $144M | — | $105M | — | — | — | — |
| Stock-based pay | $49M | $50M | $54M | $53M | $33M | $31M | $27M | $26M | $22M | $15M | $11M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $557M | $890M | $518M | $446M | $443M | $427M | $311M | $340M | $119M | $67M |
| Debt | — | $119M | $94M | $520M | $6M | $5M | $5M | $2M | — | — | — |
| Equity | — | $4.6B | $4.2B | $4.0B | $1.8B | $1.7B | $1.5B | $1.4B | $1.2B | $968M | $832M |
| Total assets | — | $5.3B | $5.3B | $5.1B | $2.1B | $2.0B | $1.7B | $1.5B | $1.3B | $1.1B | $928M |
| Shares (diluted) | 136M | 137M | 138M | 115M | 103M | 104M | 101M | 102M | 101M | 98M | 96M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 69.1% | 67.4% | 58.9% | 65.0% | 74.2% | 75.0% | 72.4% | 77.1% | 77.6% | 76.3% | 76.1% |
| Operating margin | 21.6% | 16.3% | 6.6% | 8.5% | 22.3% | 17.9% | 14.1% | 21.9% | 23.8% | 25.4% | 27.3% |
| Net margin | 17.8% | 18.3% | 4.1% | 7.8% | 18.6% | 15.6% | 13.0% | 19.8% | 21.9% | 16.9% | 18.5% |
| FCF margin | 24.4% | 20.0% | 16.1% | 10.5% | 10.2% | 22.9% | 17.1% | 12.9% | 17.1% | 16.9% | 19.0% |
| ROIC | — | 9.1% | 3.3% | 2.2% | 9.6% | 8.1% | 6.0% | 10.0% | 11.8% | 10.6% | 12.3% |
| ROE | — | 11.8% | 2.5% | 3.1% | 10.3% | 8.6% | 6.8% | 11.1% | 13.2% | 11.1% | 12.5% |
Frequently asked questions
What is Globus Medical’s annual revenue?
$2.9B in fiscal 2025 and $3.1B over the twelve months to September 30, 2026.
How much profit does Globus Medical make?
Net income was $538M in fiscal 2025 (net margin 18.3%).
Is Globus Medical’s revenue growing?
Yes: revenue rose 16.7% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.